Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists, modulators |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), PI3K family modulators(Phosphatidylinositol 3-kinase family modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Diseases | Discovery | United States | 27 Jun 2024 | |
| Sarcoma | Discovery | United States | 27 Jun 2024 | |
| Squamous Cell Carcinoma of Head and Neck | Discovery | United States | 27 Jun 2024 |





